Overview
Compare with Gevo, Inc, Amyris or FutureFuel, or pick any stock.
- TickerAMTX on Nasdaq2
- IndustryIndustrial Organic Chemicals2
- HeadquartersCupertino, United States2
- Incorporated inNV3
- Business address20400 Stevens Creek Blvd, Suite 700, Cupertino, Ca 950143
- Filer categoryAccelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI254900DQF4U5U9W7AR722
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 60620022
See how the biggest companies compare on our leaderboards
Founded in 2006 and headquartered in Cupertino, California, Aemetis, Inc. (collectively with its subsidiaries on a consolidated basis referred to herein as “Aemetis,” the “Company,” “we,” “our” or “us”) is an international renewable natural gas and renewable fuels company focused on the operation, acquisition, development, and commercialization of innovative technologies to produce low and negative carbon intensity renewable fuels that lower fuel costs and reduce emissions. We do this by building a local circular bioeconomy using agricultural products and wastes to produce low carbon, advanced renewable fuels that reduce greenhouse gas ("GHG") emissions and improve air quality. Our current operations include:5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
California Ethanol brought in 78% of the revenue AEMETIS, INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| California Ethanol | $161.8M | $153.2M |
| India Biodiesel | $92.8M | $29.7M |
| California Dairy Renewable Natural Gas | $13.0M | $14.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue66¢$208.7M
- Selling, general and admin12¢$36.5M
- Interest17¢$52.9M
- Income tax6¢$18.7M
Out of $197.6M in revenue.6 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending100¢$26.0M
Out of $3.3M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.6
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $197.6M | $267.6M |
| Production tax credits | $10.4M | $0 |
| Cost of goods sold | $208.7M | $268.2M |
| Gross loss | -$768.0K | -$580.0K |
| Selling, general and administrative expenses | $36.5M | $39.8M |
| Operating loss | -$37.2M | -$40.4M |
| Interest rate expense | $46.2M | $40.2M |
| Debt related fees and amortization expense | $6.7M | $6.5M |
| Accretion and other expenses of Series A preferred units | $8.2M | $12.7M |
| Other income | -$2.6M | -$1.4M |
| Loss before income taxes | -$95.7M | -$98.4M |
| Income tax benefit | -$18.7M | -$10.8M |
| Net loss | -$77.0M | -$87.5M |
| Foreign currency translation loss | -$990.0K | -$695.0K |
| Comprehensive loss | -$78.0M | -$88.2M |
| Basic (in dollars per share) | -$1.28 | -$1.91 |
| Diluted (in dollars per share) | -$1.28 | -$1.91 |
| Basic (in shares) | 60.0M shares | 45.9M shares |
| Diluted (in shares) | 60.0M shares | 45.9M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $4.9M | $898.0K | |
| Inventories | $11.6M | $25.4M | |
| Other current assets | $8.3M | $2.4M | |
| Total current assets | $26.9M | $44.7M | |
| Property, plant and equipment, net | $219.7M | $199.4M | |
| Operating lease right-of-use assets | $2.3M | $2.2M | |
| Total assets | $259.8M | $259.3M | |
| Current portion of long term debt | $279.1M | $63.7M | |
| Other current liabilities | $30.0M | $20.3M | |
| Total current liabilities | $371.3M | $144.0M | |
| Senior secured notes and revolving notes | $0 | $169.8M | |
| EB-5 notes | $16.0M | $21.5M | |
| Other long term debt | $47.9M | $56.2M | |
| Series A preferred units | $126.9M | $126.6M | |
| Total long term liabilities | $195.4M | $379.3M | |
| Common stock, $0.001 par value; 80,000 authorized; 66,189 and 51,139 shares issued and outstanding each period, respectively | $66.0K | $51.0K | |
| Additional paid-in capital | $340.4M | $305.3M | |
| Accumulated deficit | -$639.9M | -$562.9M | |
| Accumulated other comprehensive loss | -$7.4M | -$6.4M | |
| Total stockholders' deficit | -$306.8M | -$263.9M | -$217.0M |
| Total liabilities and stockholders' deficit | $259.8M | $259.3M | |
| Accounts receivable | $484.0K | $1.8M | |
| Prepaid expenses | $1.5M | $1.8M | |
| Tax credit sale receivable | $0 | $12.3M | |
| Other assets | $11.0M | $13.0M | |
| Accounts payable | $23.4M | $33.1M | |
| Short term borrowings | $38.7M | $26.8M | |
| Other long term liabilities | $4.6M | $5.1M | |
| Common Stock, Par Value (in dollars per share) | $0.00 | $0.00 | |
| Common Stock, Shares Authorized (in shares) | 80.0M shares | 80.0M shares | |
| Common Stock, Shares Issued (in shares) | 66.2M shares | 51.1M shares | |
| Common Stock, Shares Outstanding (in shares) | 66.2M shares | 51.1M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $4.9M | $898.0K | |
| Inventories | $11.6M | $25.4M | |
| Other current assets | $8.3M | $2.4M | |
| Total current assets | $26.9M | $44.7M | |
| Property, plant and equipment, net | $219.7M | $199.4M | |
| Operating lease right-of-use assets | $2.3M | $2.2M | |
| Total assets | $259.8M | $259.3M | |
| Current portion of long term debt | $279.1M | $63.7M | |
| Other current liabilities | $30.0M | $20.3M | |
| Total current liabilities | $371.3M | $144.0M | |
| Senior secured notes and revolving notes | $0 | $169.8M | |
| EB-5 notes | $16.0M | $21.5M | |
| Other long term debt | $47.9M | $56.2M | |
| Series A preferred units | $126.9M | $126.6M | |
| Total long term liabilities | $195.4M | $379.3M | |
| Common stock, $0.001 par value; 80,000 authorized; 66,189 and 51,139 shares issued and outstanding each period, respectively | $66.0K | $51.0K | |
| Additional paid-in capital | $340.4M | $305.3M | |
| Accumulated deficit | -$639.9M | -$562.9M | |
| Accumulated other comprehensive loss | -$7.4M | -$6.4M | |
| Total stockholders' deficit | -$306.8M | -$263.9M | -$217.0M |
| Total liabilities and stockholders' deficit | $259.8M | $259.3M | |
| Accounts receivable | $484.0K | $1.8M | |
| Prepaid expenses | $1.5M | $1.8M | |
| Tax credit sale receivable | $0 | $12.3M | |
| Other assets | $11.0M | $13.0M | |
| Accounts payable | $23.4M | $33.1M | |
| Short term borrowings | $38.7M | $26.8M | |
| Other long term liabilities | $4.6M | $5.1M | |
| Common Stock, Par Value (in dollars per share) | $0.00 | $0.00 | |
| Common Stock, Shares Authorized (in shares) | 80.0M shares | 80.0M shares | |
| Common Stock, Shares Issued (in shares) | 66.2M shares | 51.1M shares | |
| Common Stock, Shares Outstanding (in shares) | 66.2M shares | 51.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$77.0M | -$87.5M |
| Share-based compensation | $5.8M | $8.3M |
| Stock issued for services | $200.0K | $0 |
| Depreciation | $9.6M | $8.3M |
| Bad debt expense | $385.0K | $0 |
| Intangibles and other amortization expense | $46.0K | $46.0K |
| Debt related fees and amortization expense | $6.7M | $6.5M |
| Accretion and other expenses of Series A preferred units | $8.2M | $12.7M |
| Gain (Loss) on asset disposals | -$4.0K | $3.7M |
| Gain on debt/liability extinguishment | -$1.0M | -$162.0K |
| Loss on impairment of intangibles | $43.0K | $0 |
| Accounts receivable | $1.3M | $6.8M |
| Inventories | $13.1M | -$7.8M |
| Prepaid expenses | $276.0K | $1.5M |
| Tax credit sale receivable | $12.3M | -$12.3M |
| Other assets | -$4.5M | -$2.8M |
| Accounts payable | -$7.5M | -$1.3M |
| Accrued interest expense and fees, net of interest paid | $30.8M | $27.9M |
| Other liabilities | $4.6M | $3.2M |
| Net cash provided by (used in) operating activities | $3.3M | -$32.9M |
| Capital expenditures | -$26.0M | -$20.3M |
| Grant proceeds received for capital expenditures | $411.0K | $6.1M |
| Net cash used in investing activities | -$25.6M | -$14.1M |
| Proceeds from borrowings | $44.9M | $19.5M |
| Repayments of borrowings | -$37.1M | -$5.0M |
| Lender debt renewal and waiver fee payments | -$1.3M | -$1.4M |
| Payments on Series A preferred financing | -$8.3M | $0 |
| Payments on finance leases | -$168.0K | -$179.0K |
| Proceeds from sales of common stock | $28.1M | $31.8M |
| Proceeds from the exercise of stock options | $257.0K | $36.0K |
| Net cash provided by financing activities | $26.4M | $44.6M |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -$26.0K | $12.0K |
| Net change in cash and cash equivalents and restricted cash for period | $4.1M | -$2.4M |
| Cash paid for interest | $13.9M | $9.2M |
| Income taxes paid | $626.0K | $1.8M |
| Settlement of Accounts Payable via issuance of common stock | $45.0K | $265.0K |
| Subordinated debt extension fees added to debt | $1.0M | $680.0K |
| Fair value of warrants issued to subordinated debt holders | $740.0K | $916.0K |
| Lender debt extension, waiver, and other fees added to debt | $1.9M | $695.0K |
| Cumulative capital expenditures in accounts payable and accruals | $8.3M | $11.2M |
| Unpaid capital expenditures in construction financing | $3.5M | $0 |
No quarter-by-quarter statement was filed.
Corporate structure
AEMETIS, INC sits at the top of its group. 38 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of AEMETIS, INC
- BlackRock Filed SCHEDULE 13G on AEMETIS, INC, latest Jul 27, 2026 (8 filings since Feb 4, 2022)
- AllianceBernstein Filed SC 13G/A on AEMETIS, INC, latest Feb 14, 2024 (3 filings since Feb 14, 2022)
- Encompass Capital Advisors LLC Filed SC 13G/A on AEMETIS, INC, latest Feb 14, 2024 (3 filings since Feb 15, 2022)
- Grantham, Mayo, Van Otterloo & Co. LLC Filed SC 13G/A on AEMETIS, INC, latest Feb 13, 2024 (2 filings since Feb 13, 2023)
- State Street Corporation Filed SC 13G/A on AEMETIS, INC, latest Jan 20, 2023 (2 filings since Feb 9, 2022)
- Portolan Capital Management, LLC Filed SC 13G/A on AEMETIS, INC, latest Feb 11, 2022
- RENAISSANCE TECHNOLOGIES LLC Filed SC 13G/A on AEMETIS, INC, latest Feb 10, 2022
- AEMETIS, INC Cupertino, California, United States
- AE Advanced Fuels, Inc. Subsidiary · Delaware, United States
- AE Biofuels, Inc. Subsidiary · Delaware, United States
- Aemetis Advanced Biorefinery Keyes, Inc. Subsidiary · Delaware, United States
- Aemetis Advanced Fuels Keyes, Inc. Subsidiary · Delaware, United States
- Aemetis Advanced Fuels, Inc. Subsidiary · Nevada, United States
- Aemetis Advanced Products Keyes, Inc. Subsidiary · Delaware, United States
- Aemetis Advanced Products Riverbank, Inc. Subsidiary · Delaware, United States
- Aemetis Americas, Inc. Subsidiary · Nevada, United States
- Aemetis Biofuels, Inc. Subsidiary · Delaware, United States
- Aemetis Biogas 1 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 2 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 3 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 4 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 5 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 6 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 7 LLC Subsidiary · Delaware, United States
- Aemetis Biogas 8 LLC Subsidiary · Delaware, United States
- Aemetis Biogas Holdings LLC Subsidiary · Delaware, United States
- Aemetis Biogas LLC Subsidiary · Delaware, United States
- Aemetis Biogas Services LLC Subsidiary · Delaware, United States
- Aemetis Carbon Capture, Inc. Subsidiary · Nevada, United States
- Aemetis Facility Keyes, Inc. Subsidiary · Delaware, United States
- Aemetis Health Products, Inc. Subsidiary · Delaware, United States
- Aemetis International, Inc. Subsidiary · Nevada, United States
- Aemetis Properties Riverbank, Inc. Subsidiary · Delaware, United States
- and 12 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What AEMETIS, INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Land | $8.6M6 Dec 31, 2025 | $8.6M6 Dec 31, 2024 | −0.3% |
| Buildings and improvements | $200.0M6 Dec 31, 2025 | $182.7M6 Dec 31, 2024 | +9.5% |
| Machinery and equipment | $5.9M6 Dec 31, 2025 | $5.7M6 Dec 31, 2024 | +3.0% |
| Furniture and fixtures | $3.0M6 Dec 31, 2025 | $2.7M6 Dec 31, 2024 | +13.0% |
| Construction in progress | $57.0M6 Dec 31, 2025 | $46.2M6 Dec 31, 2024 | +23.5% |
| Accumulated depreciation | $73.2M6 Dec 31, 2025 | $64.9M6 Dec 31, 2024 | +12.8% |
| Finance-lease assets | $2.4M6 Dec 31, 2025 | $2.5M6 Dec 31, 2024 | −4.4% |
| Operating-lease assets (leased space) | $2.3M6 Dec 31, 2025 | $2.2M6 Dec 31, 2024 | +0.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $4.9M6 Dec 31, 2025 | $898.0K6 Dec 31, 2024 | +445.0% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $11.6M6 Dec 31, 2025 | $25.4M6 Dec 31, 2024 | −54.3% |
| Raw materials | $9.6M6 Dec 31, 2025 | $12.5M6 Dec 31, 2024 | −23.4% |
| Work in process | $1.4M6 Dec 31, 2025 | $1.7M6 Dec 31, 2024 | −16.7% |
| Finished goods | $632.0K6 Dec 31, 2025 | $11.2M6 Dec 31, 2024 | −94.4% |
Properties, in its own words
Ethanol Plant in Keyes, CA. The Keyes Plant is situated on approximately 11 acres of land that we in central California. It contains 25,284 square feet of plant building and structures and is located adjacent to the Union Pacific Railroad system to facilitate the inbound transportation of feedstock. In addition, the Aemetis Biogas LLC RNG production facility hub is also located at the Keyes Plant site, which is adjacent to regional natural gas pipeline interconnect that allows for distribution of RNG.
Real Property in Keyes, CA. We own 5.32 acres of real property located next to our Keyes Plant. We lease the property to an industrial gas company that receives CO₂ from the Keyes Plant and produces commercial grade CO₂ for sale into local markets.
The rest of Item 2
Dairy Biogas Digesters and Pipeline, Central Valley, CA. We have entered into agreements with over 50 dairies in the Central Valley of California that include current leases or terms for future leases for land to build anaerobic digesters and/or manure supply systems. The lease and manure supply agreements typically have a term of 25 years with two optional 5-year extensions. We also own about 36 miles of biogas pipeline that transports biogas from the digesters to our RNG production facility at the Keyes Plant; the pipeline is located mostly within public rights of way pursuant to licenses, with small portions located within easements on private property.
Faith Home Road, Ceres, CA. We own 8.5 acres of real property on Faith Home Road near the Keyes Plant. Currently, Aemetis Biogas uses the location for its office headquarters and warehouse. This corner property is also a strategic location for future operations supporting our development projects, including CCUS.
Jessup Road, Ceres, CA. We own approximately 1.9 acres of real property near the Keyes Plant that is a strategic location for future RNG operations.
Biodiesel Plant in Kakinada, India. The Kakinada Plant is situated on approximately 32,000 square meters of land that we own in Kakinada, India. The property is located 7.5 kilometers from the local seaport with connectivity through a third-party pipeline to the port jetty.
Kakinada Property. We own 3,683 square meters of land in Remannapalem Village, Kakinada.
India Administrative Office. In October 2024, we entered into a nine-year lease of 4,645 square feet of office space to accommodate our principal administrative, sales, and marketing facilities in Hyderabad, India.
Other Properties
Corporate Office, Cupertino, CA. Our corporate headquarters are located in leased office space at 20400 Stevens Creek Blvd., Suite 700, Cupertino, CA. This includes 9,238 square feet of rented space with a lease termination date in May 2028.
Riverbank Industrial Complex, Riverbank, CA. On December 14, 2021, we entered into real estate purchase agreements and a lease disposition and development agreement for the Riverbank Industrial Complex in Riverbank, CA. The lease commenced on April 1, 2022, with a term of fifteen years and an option to purchase the property before the end of the lease, subject to certain restrictions on the timing of the purchase. Pursuant to the lease disposition and development agreement, we serve as the master developer for the property to develop, construct, finance, operate, and maintain the leased property, and we currently have over thirty subtenants in the built up portion of the property. In the future, we plan to use the property for the construction of a sustainable aviation fuel and renewable diesel production plant and are developing a portion of the property to be used for a CCUS facility.
Goodland Energy Center, Goodland, KS. We own a large portion of the Goodland Energy Center in Goodland, Kansas, comprising approximately 93 acres of land and approximately 34,992 square feet of buildings and equipment as part of a partially completed 40 million gallon per year dry-mill ethanol plant. The ethanol plant is not operational, and we do not currently use the property for our operations.
Encumbrances
All of our real and personal property in the United States is subject to perfected first liens and security interests associated with our debt obligations as further described in Note 5. Debt, of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.
Item 2 of the 10-K filed Mar 16, 2026.5
Leadership
Who has led AEMETIS, INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerEric A. McAfee Mar 19, 2007 to now14
- Chief executive officerTimothy S. Morris Jul 5, 2006 to Jul 5, 200615
- ChairEric A. McAfee Dec 13, 2007 to Oct 9, 201316
- PresidentSurendra K. Ajjarapu Dec 11, 2007 to Jun 23, 200817
- Chief financial officerTodd Waltz Mar 18, 2010 to now18
- Chief financial officerScott Janssen Jan 13, 2009 to Feb 16, 201019
- Chief financial officerAndrew B. Foster Dec 11, 2007 to Dec 11, 200720
- Chief financial officerWilliam J. Maender Jul 5, 2006 to Dec 14, 200721
- Chief operating officerParkash P. Ahuja Jun 23, 2008 to Jun 23, 200822
Board members and other officers (19)
- EVP, GC, and Corp. Sec'yJames Michael Rockett Sep 6, 2023 to Sep 6, 202323
- Executive Vice PresidentAndrew B. Foster Feb 16, 2010 to now24
- SecretaryGeorge A. Powell Jun 23, 2006 to Jun 23, 200625
- Vice PresidentPeter Porath Jun 26, 2006 to Jun 26, 200626
- Board memberTimothy Alan Simon Nov 23, 2021 to now27
- Board memberNaomi Louise Boness Jun 17, 2020 to now28
- Board memberLydia I. Beebe Nov 22, 2016 to now29
- Board memberFrancis P. Barton Aug 14, 2012 to now30
- Board memberSteven W. Hutcheson Jul 22, 2011 to Jun 10, 201931
- Board memberJohn R. Block Oct 24, 2008 to now32
- Board memberEric A. McAfee Mar 19, 2007 to now14
- Board memberLaird Q. Cagan Dec 11, 2007 to Jan 9, 200833
- Board memberMichael L. Peterson Dec 11, 2007 to Feb 17, 201134
- Board memberMichael P. Delong Dec 11, 2007 to Dec 11, 200735
- Board memberSurendra K. Ajjarapu Dec 11, 2007 to Jun 23, 200817
- Board memberGeorge A. Powell Jun 23, 2006 to Jun 23, 200625
- Board memberPeter Porath Jun 26, 2006 to Jun 26, 200626
- Board memberTimothy S. Morris Jul 5, 2006 to Jul 5, 200615
- General counselJames Michael Rockett Jan 22, 2024 to now36
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- AE Advanced Fuels, Inc. Delaware4
- AE Biofuels, Inc. Delaware4
- Aemetis Advanced Biorefinery Keyes, Inc. Delaware4
- Aemetis Advanced Fuels Keyes, Inc. Delaware4
- Aemetis Advanced Fuels, Inc. Nevada4
- Aemetis Advanced Products Keyes, Inc. Delaware4
- Aemetis Advanced Products Riverbank, Inc. Delaware4
- Aemetis Americas, Inc. Nevada4
- Aemetis Biofuels, Inc. Delaware4
- Aemetis Biogas 1 LLC Delaware4
- Aemetis Biogas 2 LLC Delaware4
- Aemetis Biogas 3 LLC Delaware4
- Aemetis Biogas 4 LLC Delaware4
- Aemetis Biogas 5 LLC Delaware4
- Aemetis Biogas 6 LLC Delaware4
- Aemetis Biogas 7 LLC Delaware4
- Aemetis Biogas 8 LLC Delaware4
- Aemetis Biogas Holdings LLC Delaware4
- Aemetis Biogas LLC Delaware4
- Aemetis Biogas Services LLC Delaware4
- Aemetis Carbon Capture, Inc. Nevada4
- Aemetis Facility Keyes, Inc. Delaware4
- Aemetis Health Products, Inc. Delaware4
- Aemetis International, Inc. Nevada4
All 37 listed subsidiaries
- Aemetis Properties Riverbank, Inc. Delaware4
- Aemetis Property Keyes, Inc. Delaware4
- Aemetis RNG Fuels 1 LLC California4
- Aemetis Riverbank, Inc. Delaware4
- Aemetis Technologies, Inc. Delaware4
- Caprock Project Holding, Inc. Delaware4
- EdenIQ Acquisition Corp Delaware4
- Energy Efficiency Holdings LLC Delaware4
- Energy Enzymes, Inc. Delaware4
- Goodland Advanced Fuels, Inc. Delaware4
- MVR Services LLC California4
- Riverbank Well 1, Inc. California4
- Universal Biofuels Private Limited India4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
Timeline
- Aug 6, 20268-K Results of operations; Regulation FD disclosure37
- May 26, 20268-K Shareholder vote38
- May 7, 20268-K Results of operations; Regulation FD disclosure39
- Mar 16, 20268-K Change of auditor40
- Mar 12, 20268-K Results of operations; Regulation FD disclosure41
- Feb 19, 20268-K Bylaws or fiscal year changed; Shareholder vote; Other events42
- Feb 6, 20268-K Entered a material agreement43
- Jan 28, 20268-K Entered a material agreement; Executive or director change; Other events44
- Nov 6, 20258-K Results of operations; Regulation FD disclosure45
- Oct 21, 20258-K Entered a material agreement46
- Aug 7, 20258-K Results of operations; Regulation FD disclosure47
- May 16, 20258-K Shareholder vote48
- Oct 27, 2021Founded AEMETIS, INC is founded2
- Mar 19, 2007New chief executive Eric A. McAfee becomes CEO14
- Jul 5, 2006New chief executive Timothy S. Morris becomes CEO15
Calendar
Coming up
- Nov 5, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.37) a share, on Nov 6, 2025.49
When it reported results
- Aug 6, 2026Reported quarterly or annual results37
- May 7, 2026Reported quarterly or annual results39
- Mar 12, 2026Reported quarterly or annual results41
- Nov 6, 2025Reported quarterly or annual results45
- Aug 7, 2025Reported quarterly or annual results47
- May 8, 2025Reported quarterly or annual results50
- Mar 13, 2025Reported quarterly or annual results51
- Nov 12, 2024Reported quarterly or annual results52
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
229 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 56 major events, 90 insider forms, 20 large holders, 43 other. The latest 20:
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 27, 2026SCHEDULE 13G EDGAR
- Jun 11, 20264 PRIMARY DOCUMENT EDGAR
- Jun 10, 2026144 EDGAR
- May 26, 20268-K EDGAR
- May 7, 202610-Q EDGAR
- May 7, 20268-K EDGAR
- Apr 7, 2026DEF 14A EDGAR
- Mar 23, 20264 PRIMARY DOCUMENT EDGAR
- Mar 23, 20264 PRIMARY DOCUMENT EDGAR
- Mar 23, 20264 PRIMARY DOCUMENT EDGAR
- Mar 23, 20264 PRIMARY DOCUMENT EDGAR
- Mar 23, 20264 PRIMARY DOCUMENT EDGAR
- Mar 23, 20264 PRIMARY DOCUMENT EDGAR
- Mar 16, 20268-K EDGAR
- Mar 16, 2026S-8 EDGAR
- Mar 16, 202610-K EDGAR
- Mar 12, 20268-K EDGAR
- Feb 19, 20268-K EDGAR
The 229 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
16 open-market trades by officers, directors and large owners since October 2021: 1 buys and 15 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Simon Timothy AlanDirector | Sale | 10,000 | $2.05 | $20.5K | Form 4 |
| Aug 14, 2025 | BARTON FRANCIS PDirector | Sale | 26,452 | $2.53 | $66.9K | Form 4 |
| May 23, 2024 | BLOCK JOHN RDirector | Sale | 51,580 | $3.49 | $180.0K | Form 4 |
| Sep 12, 2023 | Boness Naomi LouiseDirector | Sale | 15,000 | $5.65 | $84.8K | Form 4 |
| Jun 16, 2023 | BLOCK JOHN RDirector | Sale | 19,205 | $6.30 | $121.0K | Form 4 |
| Mar 14, 2022 | BLOCK JOHN RDirector | Sale | 65,536 | $12.12 | $794.3K | Form 4 |
| Dec 20, 2021 | Simon Timothy AlanDirector | Buy | 1,000 | $12.21 | $12.2K | Form 4 |
| Nov 8, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 9,533 | $23.09 | $220.1K | Form 4 |
| Nov 5, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 1,300 | $23.00 | $29.9K | Form 4 |
| Nov 3, 2021 | BARTON FRANCIS PDirector | Sale | 10,555 | $21.12 | $222.9K | Form 4 |
| Nov 2, 2021 | BARTON FRANCIS PDirector | Sale | 9,445 | $21.13 | $199.6K | Form 4 |
| Oct 25, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 11,317 | $20.07 | $227.1K | Form 4 |
| Oct 22, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 100 | $20.00 | $2.0K | Form 4 |
| Oct 21, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 213 | $19.96 | $4.3K | Form 4 |
| Oct 20, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 15,000 | $19.08 | $286.2K | Form 4 |
| Oct 18, 2021 | FOSTER ANDREW BExecutive Vice President | Sale | 71,167 | $17.90 | $1.3M | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G, 8 filings Feb 4, 2022 to Jul 27, 202653
- AllianceBernsteinSC 13G/A, 3 filings Feb 14, 2022 to Feb 14, 202454
- Encompass Capital Advisors LLCSC 13G/A, 3 filings Feb 15, 2022 to Feb 14, 202455
- Grantham, Mayo, Van Otterloo & Co. LLCSC 13G/A, 2 filings Feb 13, 2023 to Feb 13, 202456
- State Street CorporationSC 13G/A, 2 filings Feb 9, 2022 to Jan 20, 202357
- Portolan Capital Management, LLCSC 13G/A, 1 filing Feb 11, 202258
- RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 1 filing Feb 10, 202259
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Eric A. McAfee | 63 | $500.0K | $1.9M60 |
| 2025 | J. Michael Rockett | 61 | $400.0K | $1.0M60 |
| 2025 | Todd A. Waltz | 64 | $430.0K | $1.0M60 |
| 2025 | Andrew B. Foster | 60 | $400.0K | $1.0M60 |
| 2025 | Sanjeev Gupta | 66 | $400.0K | $1.0M60 |
| 2024 | Chief Executive Officer | $360.0K | $1.6M60 | |
| 2024 | Chief Financial Officer | $300.0K | $839.5K60 | |
| 2024 | Chief Operating Officer | $280.0K | $818.7K60 | |
| 2024 | Executive VicePresident | $280.0K | $818.7K60 | |
| 2024 | General Counsel | $280.0K | $818.7K60 | |
| 2023 | Chief Executive Officer | $360.0K | $1.8M60 | |
| 2023 | Chief Financial Officer | $300.0K | $1.1M60 | |
| 2023 | Chief Operating Officer | $280.0K | $1.1M60 | |
| 2023 | Executive VicePresident | $280.0K | $1.1M60 | |
| 2023 | General Counsel | $96.9K | $423.3K60 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 88. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 3,970,470 | $6.5M | 0.0% | +3,337,254 |
| Vanguard Capital Management LLC | 2,991,239 | $4.9M | 0.0% | +356,586 |
| Geode Capital Management, LLC | 1,720,035 | $2.8M | 0.0% | +989,419 |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1,064,317 | $1.7M | 0.0% | +14,300 |
| State Street Corp | 726,199 | $1.2M | 0.0% | +424,300 |
| D. E. Shaw & Co., Inc. | 623,028 | $1.0M | 0.0% | +77,599 |
| Northern Trust Corp | 507,989 | $833.1K | 0.0% | +372,755 |
| Vanguard Portfolio Management LLC | 442,363 | $725.5K | 0.0% | New |
| Vanguard Fiduciary Trust Co | 438,939 | $719.9K | 0.0% | +60,836 |
| Susquehanna International Group, Llp | 400,722 | $657.2K | 0.0% | +19,780 |
| Millennium Management LLC | 396,403 | $650.1K | 0.0% | −20,418 |
| Marshall Wace, Llp | 298,800 | $490.0K | 0.0% | −580,883 |
| Citadel Advisors LLC | 267,309 | $438.4K | 0.0% | −202,406 |
| Two Sigma Investments, LP | 267,204 | $438.2K | 0.0% | −113,044 |
| CIBC Bancorp USA Inc. | 253,879 | $416.4K | 0.0% | +3,579 |
| Goldman Sachs Group Inc | 199,701 | $327.5K | 0.0% | +2,152 |
| Hamilton Capital Partners, LLC | 195,313 | $320.3K | 0.1% | New |
| Charles Schwab Investment Management Inc | 195,288 | $320.3K | 0.0% | New |
| Bank of New York Mellon Corp | 172,306 | $282.6K | 0.0% | New |
| LPL Financial LLC | 142,033 | $232.9K | 0.0% | +6,129 |
| Osaic Holdings, Inc. | 137,524 | $225.5K | 0.0% | +10,580 |
| Bridgeway Capital Management, LLC | 126,900 | $208.1K | 0.0% | +25,000 |
| J. Derek Lewis & Associates Inc. | 125,000 | $205.0K | 0.0% | −76,351 |
| XTX Topco Ltd | 123,222 | $202.1K | 0.0% | New |
| Stifel Financial Corp | 100,413 | $164.7K | 0.0% | +11,500 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
6 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Apr 12, 2021 | Brian J. MastRepublican, House | Sale | $50,001 - $100,000 | +181.3% | Report |
| Apr 12, 2021 | Brian J. MastRepublican, House | Sale | $15,001 - $50,000 | +181.3% | Report |
| Mar 4, 2021 | Brian J. MastRepublican, House | Buy | $1,001 - $15,000 | −194.3% | Report |
| Mar 4, 2021 | Brian J. MastRepublican, House | Buy | $15,001 - $50,000 | −194.3% | Report |
| Mar 4, 2021 | Brian J. MastRepublican, House | Buy | $1,001 - $15,000 | −194.3% | Report |
| Mar 4, 2021 | Brian J. MastRepublican, House | Buy | $1,001 - $15,000 | −194.3% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How AEMETIS, INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAEMETIS, INC1
- CIK0000738214
- Employer ID (EIN)26-14075445
- Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inDelaware5
- Fiscal year endsDecember 311
- Industry code (SIC)2860 Industrial Organic Chemicals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address20400 Stevens Creek Blvd, Suite 700, Cupertino, CA 950141
- Phone408-517-33041
- Shares outstanding72,169,594 as of Jul 31, 202612
- Public float$142.1M as of Jun 30, 20255
- AuditorRSM US LLP, Des Moines, Iowa PCAOB ID 49; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceDec 3, 20041
- Filings856 in all: 4 (315), 8-K (190), 10-Q (53), 10QSB (24), 3 (24), UPLOAD (21), SC 13G/A (19), 10-K (18)1
All 55 form types
S-8 (17), SC 13G (15), CORRESP (14), DEF 14A (14), 5 (12), 10KSB (8), DEFA14A (8), 424B5 (7), D (7), PRE 14A (7), 144 (6), 8-K/A (6), EFFECT (6), NT 10-K (6), NT 10-Q (6), SC 13D (6), S-3 (5), 4/A (4), 10-K/A (3), CT ORDER (3), 3/A (2), 424B2 (2), 5/A (2), D/A (2), S-3/A (2), 10-Q/A (1), 10KSB/A (1), 10QSB/A (1), 10SB12G (1), 424B3 (1), 8-A12B (1), 8-A12B/A (1), CERTNAS (1), DEF 14C (1), DEFM14C (1), DEFR14A (1), NT 10-K/A (1), POS AM (1), PRE 14C (1), PREM14C (1), PRER14A (1), REGDEX (1), S-1 (1), SC 14F1 (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1), SEC STAFF ACTION (1)
- Latest filingsAnnual report (10-K) Mar 16, 2026
Quarterly report (10-Q) Aug 6, 2026
Proxy statement (DEF 14A) Apr 7, 2026
Latest 8-K (8-K) Aug 6, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.001 par value | AMTX | NASDAQ |
From the cover page of the 10-K filed Mar 16, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks AEMETIS, INC names in Item 1A of its 10-K filed Mar 16, 2026: 52 risks under these headings, as written.5
- Risks Related to our Overall Business
- We are currently not profitable and historically we have incurred significant losses. If we incur continued losses, we may have to curtail our operations, which may prevent us from successfully operating and expanding our business.
- Our indebtedness, preference payments, and interest expense could limit cash flow and adversely affect operations and our ability to make full payment on outstanding debt.
- Our business is dependent on external financing and cash from operations to service debt and fund future growth.
- We may be unable to repay or refinance our Third Eye Capital Debt upon maturity.
- We are dependent upon our working capital agreements with J.D. Heiskell and other key vendors.
- Our results from operations are primarily dependent on the spread between the feedstock and energy we purchase and the fuel, animal feed, and other products we sell.
- The price of ethanol is volatile and subject to large fluctuations, and increased ethanol production may cause a decline in ethanol prices or prevent ethanol prices from rising, either of which could adversely impact our results of operations, cash flows and financial condition.
- We may be unable to execute our business plan.
- We may not be able to recover the costs of our substantial investments in capital improvements and additions, and the actual cost of such improvements and additions may be significantly higher than we anticipate.
- We are in the process of developing biogas digesters, CCUS, SAF/RD, expanded biodiesel production and other projects, and the success of such projects depends on many factors including but not limited to, cash flows and revenue projections being achieved.
- We rely on the availability of tax credits, carbon credits, grants, and other regulatory and financial incentives. The expiration, elimination, modification, or reduction of these regulations, credits, and incentives could adversely impact our business.
The other 41 risks
- We are dependent on, and vulnerable to any difficulties of, our principal suppliers and customers.
- We may not receive the funds we expect under our EB-5 program.
- We face competition for our transportation fuels products from providers of petroleum-based products and from other companies seeking to provide alternatives to these products, many of whom have greater resources and experience than we do, and if we cannot compete effectively against these companies, we may not be successful.
- Our operations are subject to environmental, health, and safety laws, regulations, and liabilities.
- Our business is affected by greenhouse gas and climate change regulation.
- A change in government policies may cause a decline in the demand for our products.
- Concerns regarding the environmental impact of biofuel production could affect public policy which could impair our ability to operate at a profit and substantially harm our revenues and operating margins.
- We may encounter unanticipated difficulties in converting the Keyes Plant to accommodate alternative feedstocks, new chemicals used in the fermentation and distillation process, or new mechanical production equipment.
- We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act.
- A substantial portion of our assets and operations are located in India, and we are subject to regulatory, economic and political uncertainties in India.
- Currency fluctuations between the Indian rupee and the U.S. dollar could have a material adverse effect on our results of operations.
- We could be subject to restrictions on the movement of cash and the exchange of foreign currencies that could limit our access to cash held in our India subsidiary to fund our U.S. operations or otherwise make investments where needed.
- Aemetis, Inc. is a holding and management company and there are significant limitations on our ability to receive distributions from our subsidiaries.
- Our ability to utilize our NOL carryforwards may be limited.
- Non-U.S. stockholders of our common stock, in certain situations, could be subject to U.S. federal income tax on the gain from the sale, exchange or other disposition of our common stock.
- We are subject to covenants and other operating restrictions under the terms of our debt, which may restrict our ability to engage in some business transactions.
- We may be subject to liabilities and losses that may not be covered by insurance.
- Our mergers, acquisitions, partnerships, and joint ventures may not be as beneficial as we anticipate.
- Our business systems may be significantly disrupted upon the occurrence of a catastrophic event or cyberattack.
- Adverse weather conditions, including as a result of climate change, may adversely affect the availability, quality, and price of agricultural commodities and agricultural commodity products, as well as our operations and operating results.
- We may be unable to protect our intellectual property.
- We may not be able to successfully develop and commercialize our technologies, which may require us to curtail or cease our research and development activities.
- Technological advances and changes in production methods in the biomass-based biofuel industry and renewable chemical industry could render our plants obsolete and adversely affect our ability to compete.
- Disruption in the supply chain could materially adversely affect our business.
- Failure to remediate a material weakness in, or inherent limitations associated with, internal accounting controls could result in material misstatements in our financial statements.
- Risks related to ownership of our stock
- Our stock price is highly volatile, which could result in substantial losses for investors purchasing shares of our common stock and in litigation against us.
- We do not currently plan to pay dividends in the next few years.
- Our principal shareholders hold a substantial amount of our common stock.
- The exercise of outstanding options and warrants to purchase our common stock could substantially dilute your investment and reduce the voting power of your shares, impeding our ability to obtain additional financing and cause us to incur additional expenses.
- Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or other employees.
- Provisions in our certificate of incorporation and bylaws may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our common stock and could entrench management.
- General Risk Factors
- Our success depends in part on recruiting and retaining key personnel and, if we fail to do so, it may be more difficult for us to execute our business strategy.
- Our operations subject us to risks associated with foreign laws, policies, regulations, and markets.
- Operational difficulties at our facilities may negatively impact our business.
- Our success depends on our ability to manage the growth of our operations.
- Our business may be subject to natural forces beyond our control.
- U.S. tax law changes could materially affect the tax aspects of our business and the industries in which we compete.
- Future sales and issuances of rights to purchase common stock by us could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.
- Interest rates could change substantially, materially impacting our profitability.
- Inflation, including as a result of commodity price inflation or supply chain constraints due to wars, may adversely impact our results of operations.
- The impact of potential tariffs under the current presidential administration is uncertain.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAEMETIS, INC filings on SEC EDGAR
- 2
- 3SEC EDGARAEMETIS, INC filings on SEC EDGAR
- 4
- 5
- 6SEC EDGARAEMETIS, INC 10-K for fiscal 2025
- 7SEC EDGARAEMETIS, INC 10-K for fiscal 2019
- 8SEC EDGARAEMETIS, INC 10-K for fiscal 2022
- 9SEC EDGARAEMETIS, INC 10-K for fiscal 2021
- 10SEC EDGARAEMETIS, INC 10-K for fiscal 2023
- 11SEC EDGARAEMETIS, INC 10-Q for fiscal 2026
- 12SEC EDGARAEMETIS, INC 10-Q for fiscal 2026
- 13SEC EDGARAEMETIS, INC 10-K for fiscal 2019
- 14
- 15
- 16SEC EDGAREric A. McAfee, Chair
- 17SEC EDGARSurendra K. Ajjarapu, President
- 18SEC EDGARTodd Waltz, Chief financial officer
- 19
- 20
- 21
- 22
- 23
- 24
- 25SEC EDGARGeorge A. Powell, Secretary
- 26SEC EDGARPeter Porath, Vice President
- 27SEC EDGARTimothy Alan Simon, Board member
- 28SEC EDGARNaomi Louise Boness, Board member
- 29SEC EDGARLydia I. Beebe, Board member
- 30SEC EDGARFrancis P. Barton, Board member
- 31SEC EDGARSteven W. Hutcheson, Board member
- 32SEC EDGARJohn R. Block, Board member
- 33SEC EDGARLaird Q. Cagan, Board member
- 34SEC EDGARMichael L. Peterson, Board member
- 35SEC EDGARMichael P. Delong, Board member
- 36
- 37
- 38SEC EDGARShareholder vote
- 39
- 40SEC EDGARChange of auditor
- 41
- 42
- 43SEC EDGAREntered a material agreement
- 44
- 45
- 46SEC EDGAREntered a material agreement
- 47
- 48SEC EDGARShareholder vote
- 49NasdaqNasdaq calendar
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60